Intimate partner violence (IPV) is a widespread public health issue impacting almost of half of individuals in the United States during their lifetime. Pharmacists' accessibility in communities and expanding provision of comprehensive sexual and reproductive health services, including new over-the-counter contraception options, positions them to screen for IPV and connect patients to resources. The American College of Obstetrician and Gynecologists recommends regular screening for IPV and reproductive coercion especially when engaging patients in sexual and reproductive health services, which are expanding within pharmacies. A review of statewide protocols for pharmacist-prescribed contraception and pharmacist-initiated HIV pre-and post-exposure prophylaxis (PrEP/PEP) found growing inclusion of IPV considerations for pharmacists to follow. This signals a precedent for integrating screening and referral practices more broadly. Pharmacists, however, typically do not receive comprehensive education on recognizing IPV or supporting affected individuals. To address this gap, Schools and Colleges of Pharmacy should embed IPV training into existing curricula. This includes recognizing signs of abuse, conducting routine screenings, and making informed referrals. Such education aligns with ACPE 2025 Standards and supports the development of advocacy-oriented pharmacists.
No takes yet. Share an insight, caveat, or question.
Schneider et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: